Reference

1. Wilson PD, Falkenstein D. The pathology of human renal cystic disease. In: Dodd SM,ed.Tubulointestinal and cystic disease of the kidney. Vol. 88 of Current topics in pathology. Berlin, Germany: Springer Verlag,1995:1-50. 
2. WELLING LW, GRANTHAM JJ: Cystic disease of the kidney, in Renal Pathology, edited by TISHER C, BRENNER B, 
3. Philadelphia,Lippincott, 1989, pp. 1233—1277 
4. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007;369:1287–301. [PubMed: 17434405] 
5. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369(9569):1287–1301. 
6. Gabow PA: Autosomal dominant polycystic kidney diseasemore than a renal disease [Reviewl. Am J Kidney Dis 1990; 16:403-4 13. 
7. Scheffers MS, van der Bent P, Prins F, Spruit L, Breuning MH, Litvinov SV, de Heer E, Peters DJM: Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet 9: 2743–2750, 2000. 
8. Patel V, Chowdhury R, Igarashi P. Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens 2009;18:99-106. 
9. Pei Y, Paterson AD, Wang KR, et al. Bi-lineal disease and transheterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet 2001;68:355-63. 
10. Blyth H, Ockenden BG: Polycystic disease of kidneys and liver presenting in childhood. J Med Genet 8: 257–284, 1971. 
11. Hildebrandt, F., Attanasio, M. & Otto, E. Nephronophthisis: disease mechanisms of a ciliopathy. J. Am. Soc. Nephrol. 20, 23– 35 (2009). 
12. WELLING LW, GRANTHAM JJ: Cystic and developmental diseases of the kidney, in The Kidney, edited by BRENNER BM, RECTOR JRFC (3rd ed). Philadelphia, W.B. Sanders Company, 1986, p. 1341. 
13. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007. 
14. Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 2002;13:2384–2398. [PubMed: 12191984]. 
15. US Renal Data Services. Table A.1, Incident counts of reported 
16. ESRD: all patients. USRDS 2008 Annual Data Report, Vol. 3, page 
17. 7.
18. Wang X, Wu Y, Ward CJ, Harris PC, Torres VE: Vasopressin directly regulates cyst growth in the PCK rat. J Am Soc Nephrol 19: 102–108, 2008. 
19. Li Y, Wright JM, Qian F, Germino GG, Guggino WB: Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+signaling. J Biol Chem 280: 41298– 41306,2005. 
20. Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 1999;353:103–107. 
21. Reeders, S. T., Breuning, M. H., Davies, K. E., Nicholls, R. D., 
22. Jarman, A. P., Higgs, D. R., Pearson, P. L. and Weath-erall, D. J. (1985) A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317: 542 – 544. 
23. Persu A, Duyme M, Pirson Y, Lens XM, Messiaen T, Breuning MH, Chauveau D, Levy M, Grunfeld JP, Devuyst O: Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int 2004; 66:2132–2136. 
24. Pisitkun T, Shen RF, Knepper MA: Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101: 13368–13373, 2004. 
25. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996;87:979–987.